Inflow

Inflow leverages its proprietary CBT-based program and the acquisition of Lina Health to become a dominant player in the rapidly growing ADHD digital therapy market. Expanding its coaching and diagnostic services, Inflow achieves significant market penetration, reaching over $100M ARR by 2028. This success, coupled with strong clinical outcomes, justifies an acquisition by a major digital health platform or a successful IPO at a valuation of $240M, a 4x multiple on the estimated current valuation.

Inflow continues to grow steadily, maintaining its position as a leading app for ADHD self-management. It expands its user base and subscription revenue, reaching approximately $30M ARR by 2028. While facing competition from broader mental wellness apps, its specialized focus and CBT-based approach allow for a moderate exit, likely through acquisition by a mid-sized healthcare technology company, at an estimated valuation of $105M.

Increased competition from well-funded incumbents like Teladoc/BetterHelp or new specialized apps, coupled with challenges in user acquisition and retention, leads to slower-than-expected growth. Regulatory hurdles or a lack of strong clinical trial data further dampen prospects. The company struggles to raise subsequent funding rounds at a favorable valuation, resulting in a down round or a distressed acquisition at a valuation of $12M, significantly eroding common stock value due to liquidation preferences.